Navigation Links
FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations,,FDA Regulations

Is FDA Equipped to Meet Pace of Innovations and a Health Conscious Public?

WASHINGTON, April 30, 2007 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) must adapt to the most significant changes in the history of healthcare, Commissioner Andrew von Eschenbach told attendees at the Food and Drug Law Institute's 50th Annual Conference April 12 in Bethesda, Md.

FDA must find creative "bridging" ways to use its limited financial and personnel resources to deal with the challenges led by scientific breakthroughs increasing health benefits but also risks in foods, drugs and devices, von Eschenbach told the industry representatives, compliance officers, health policymakers, physicians, regulators and attorneys attending the FDLI meeting.

Keynote speaker Sen. Ron Wyden (D-Ore.), sponsor of The Healthy Americans Act -- omnibus legislation to reform the healthcare system in the United States -- said that it was vitally important that Democrats and Republicans work together to enable FDA to improve the drug delivery process. The Healthy Americans Act seeks to provide universal, affordable, quality health coverage to all Americans.

The landmark FDLI conference focused on the impact of scintillating scientific discoveries that are driving technological innovation in health care and the impact of those changes on FDA and pharmaceutical and device manufacturers, as well as the food industry. Industry leaders, including representatives from Siemens and Amgen, provided a glimpse into the future of personalized medicine. Expert panels discussed how these innovations would affect reimbursement, claims, food marketing and safety, clinical research, drug evaluation, radiological health and veterinary medicine. Representatives from all major FDA centers provided inside information on new agency initiatives in these areas.

This 50th FDLI annual meeting also marked a reinvigorated FDLI focus on providing a forum for the constructive development of law needed to keep pace with new technology and its impact on food and drug regulation. "The future of healthcare is rooted in high tech, and FDLI is positioned to facilitate avenues where the regulatory systems can become fast and flexible enough to handle the onslaught of innovation," said Jim Wood, chairman of the Board. "The challenge for science, industry and government will be to collaborate to look for efficiencies which will help enable that solutions can be delivered for the public health, safer and faster -- and FDLI will endeavor to play a catalytic role in that endeavor," added Jim Kelly, president and CEO of FDLI.

PowerPoint presentations by conference faculty can be accessed by visiting http://www.fdli.org/conf/handouts.html. Several plenary speeches will be published in the next issue of the Food and Drug Law Journal.

Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug Law Journal; the bimonthly magazine Update; FDA Directory; and dozens of books and publications for attorneys, regulatory affairs practitioners, scientists, health care professionals, government employees and marketers in the food and drug field.

CONTACT: Michael Levin-Epstein, Editor-in-Chief of FDLI, +1-202-222-0897, mdl@fdli.org

Web site: http://www.fdli.org/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
4. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
5. Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
6. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
7. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
8. MaxCyte and Medinet to Present at the 13th Annual Meeting of the International Society for Cellular Therapy (ISCT) in Sydney, Australia
9. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
10. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
11. Neurogen Proprietary Insomnia Compound Data for Two Studies Presented at Associated Professional Sleep Societies Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
Breaking Medicine News(10 mins):